These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27090113)

  • 1. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.
    Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM
    Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
    Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
    Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.
    Adusumilli P; Elsayed N; Theophanous S; Samuel R; Cooper R; Casanova N; Tolan DJ; Gilbert A; Scarsbrook AF
    Eur Radiol; 2022 Aug; 32(8):5086-5096. PubMed ID: 35274187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and Clinical Impact of Persistent Disease Diagnosed on Diffusion-Weighted Imaging and Accuracy of Pelvic Nodal Assessment on Magnetic Resonance Imaging for Squamous Cell Carcinoma of the Anus in the 6-Month Interval Post Chemoradiotherapy.
    Fernandes MC; Charbel C; Romesser PB; Ucpinar BA; Homsi ME; Yildirim O; Fuqua JL; Rodriguez LA; Zheng J; Capanu M; Gollub MJ; Horvat N
    Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):120-129. PubMed ID: 38462017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer.
    Owczarczyk K; Prezzi D; Cascino M; Kozarski R; Gaya A; Siddique M; Cook GJ; Glynne-Jones R; Goh V
    Radiother Oncol; 2019 May; 134():119-126. PubMed ID: 31005205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
    Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
    Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus.
    Muirhead R; Bulte D; Cooke R; Chu KY; Durrant L; Goh V; Jacobs C; Ng SM; Strauss VY; Virdee PS; Qi C; Hawkins MA
    Clin Oncol (R Coll Radiol); 2020 Dec; 32(12):874-883. PubMed ID: 33023818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
    Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
    Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
    Gravante G; Stephenson JA; Elshaer M; Osman A; Vasanthan S; Mullineux JH; Gani MAD; Sharpe D; Yeung J; Norwood M; Miller A; Boyle K; Hemingway D
    J Surg Oncol; 2018 Feb; 117(2):269-274. PubMed ID: 28891266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
    Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
    Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma.
    Shakir R; Adams R; Cooper R; Downing A; Geh I; Gilbert D; Jacobs C; Jones C; Lorimer C; Namelo WC; Sebag-Montefiore D; Shaw P; Muirhead R
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):329-339. PubMed ID: 31629837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
    Duimering A; Riauka T; Nijjar Y; Ghosh S; MacEwan R; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Nijjar T; Fairchild A; Mulder K; Doll C; Wong C; Joseph K
    Radiother Oncol; 2019 Jul; 136():21-28. PubMed ID: 31015125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
    Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.
    Joseph K; Al Habsi Z; Abraham A; Elangovan A; Ghosh S; Pham T; Shreekumar D; Ramji Z; Paulson K; Tankel K; Usmani N; Severin D; Schiller D; Wong C; Mulder K; Karachiwala H; Doll C; King K; Nijjar T
    Radiother Oncol; 2024 Jul; 196():110219. PubMed ID: 38479443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
    Takahashi R; Osumi H; Wakatsuki T; Yamamoto N; Taguchi S; Nakayama I; Ooki A; Ogura M; Takahari D; Chin K; Yamaguchi K; Shinozaki E
    Int J Clin Oncol; 2024 Aug; 29(8):1161-1172. PubMed ID: 38819609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
    Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
    Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapeutic strategies for anal squamous cell carcinoma in Japan.
    Takashima A; Shimada Y; Hamaguchi T; Ito Y; Masaki T; Yamaguchi S; Kondo Y; Saito N; Kato T; Ohue M; Higashino M; Moriya Y;
    Int J Clin Oncol; 2009 Oct; 14(5):416-20. PubMed ID: 19856049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.
    Glynne-Jones R; Kadalayil L; Meadows HM; Cunningham D; Samuel L; Geh JI; Lowdell C; James R; Beare S; Begum R; Ledermann JA; Sebag-Montefiore D;
    Ann Oncol; 2014 Aug; 25(8):1616-22. PubMed ID: 24827136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection.
    Camandaroba MPG; Iseas S; Oliveira C; Taboada RG; Xerfan MP; Mauro CC; Silva VS; Barros M; de Jesus VHF; Felismino T; Aguiar S; Gobo ML; Mello CA; Riechelmann RP
    Clin Colorectal Cancer; 2020 Sep; 19(3):e129-e136. PubMed ID: 32389596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.